Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
allogeneic hepatocyte
- Development stage
- Phase 2
- Lead developer
- bit.bio
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intraportal, Intraperitoneal, Intrahepatic, Extracorporeal
01
Overview
Allogeneic hepatocyte refers to liver cells (hepatocytes) isolated from a donor of the same species but with a different genetic background, intended for transplantation into another individual. These cells are used as an alternative to whole organ liver transplantation, particularly in cases of acute or chronic liver failure and certain inherited metabolic disorders. The primary mechanism involves engraftment and functional replacement of damaged or deficient host hepatocytes, thereby restoring essential liver functions such as albumin synthesis and detoxification. Allogeneic hepatocyte transplantation faces challenges related to immune rejection; encapsulation technologies (e.g., hydrogel-based microcapsules) are being developed to protect transplanted cells from immune attack while maintaining their viability and function[1][6]. This approach is under investigation for use in bioartificial liver devices and direct cell therapy.
- Other names
- allogeneic hepatocytes
Beyond the preview
Go deeper on allogeneic hepatocyte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on allogeneic hepatocyte.